Profound Medical PROF Recurring Non Capital — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Profound Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Profound Medical's recurring non capital — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Profound Medical's recurring non capital — revenue?
- Profound Medical (PROF) reported recurring non capital — revenue of $2.47M in Q1 2026.
- How has Profound Medical's recurring non capital — revenue changed year-over-year?
- Profound Medical's recurring non capital — revenue increased by 37.4% year-over-year, from $1.8M to $2.47M.
- What is the long-term trend for Profound Medical's recurring non capital — revenue?
- Over 2 years (2023 to 2025), Profound Medical's recurring non capital — revenue has grown at a 19.6% compound annual growth rate (CAGR), from $6.81M to $9.73M.
- What does recurring non capital — revenue mean?
- This metric represents the total revenue generated from non-capitalized, recurring sources within a specific business segment. It typically encompasses service contracts, disposables, or subscription-based access fees that provide predictable, ongoing cash flow independent of initial hardware sales. Tracking this figure helps investors assess the stability and scalability of the company's long-term service and support revenue model.